Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy
Summary Purpose: Glutamic acid decarboxylase antibodies (GADAs) have been detected in patients with epilepsy, but the clinical determinants of epilepsy associated with GADA have not been defined. Methods: We analyzed GADA with a radioimmunoassay in sera of 253 well‐characterized patients with epil...
Saved in:
Published in | Epilepsia (Copenhagen) Vol. 51; no. 5; pp. 760 - 767 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.05.2010
Wiley-Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!